Holen Sie sich die Stockscreener-App
0.6869
4.06%
0.0268
Vorhandelsmarkt:
.70
0.0131
+1.91%
Karyopharm Therapeutics Inc Aktie (KPTI) Neueste Nachrichten
Karyopharm Therapeutics’ (KPTI) “Buy” Rating Reiterated at HC Wainwright - Defense World
What is HC Wainwright’s Estimate for KPTI FY2024 Earnings? - Defense World
What is HC Wainwright's Forecast for KPTI FY2024 Earnings? - MarketBeat
HC Wainwright Reiterates Buy Rating for Karyopharm Therapeutics (NASDAQ:KPTI) - MarketBeat
Karyopharm Therapeutics' SWOT analysis: oncology firm's stock faces pivotal year - Investing.com India
Karyopharm Therapeutics’ SWOT analysis: oncology firm’s stock faces pivotal year - Investing.com Nigeria
Jane Street Group LLC Sells 1,345,226 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat
Jane Street Group LLC Has $170,000 Stake in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World
KPTIKaryopharm Therapeutics Inc. Latest Stock News & Market Updates - StockTitan
Karyopharm announces preliminary 2024 revenue - MSN
Karyopharm Reports $145M Revenue for 2024, Advances Phase 3 Myelofibrosis Trial - StockTitan
Why Karyopharm Therapeutics (KPTI) Is Among the Best Penny Stocks to Invest In According to Media? - MSN
Geode Capital Management LLC Has $1.13 Million Stake in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World
Barclays PLC Has $79,000 Stock Holdings in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World
Barclays PLC Sells 777,507 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat
Karyopharm CEO sells common stock for $3,175 By Investing.com - Investing.com Canada
12 Best Penny Stocks to Invest in According to the Media - Insider Monkey
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Position Reduced by State Street Corp - Defense World
Karyopharm appoints new CFO effective January 3 By Investing.com - Investing.com Australia
Karyopharm appoints new CFO effective January 3 - Investing.com India
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
Karyopharm Appoints Lori Macomber as Chief Financial Officer - citybiz
Karyopharm Welcomes New Chief Financial Officer - Contract Pharma
Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer, Effective January 3, 2025 - Marketscreener.com
Karyopharm appoints new CFO to bolster financial strategy - Investing.com
Karyopharm Therapeutics names Lori Macomber as CFO - MSN
Karyopharm Appoints Lori Macomber as New CFO - TipRanks
Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer - Citizentribune
Karyopharm Therapeutics (NASDAQ:KPTI) Shares Pass Below 50 Day Moving AverageWhat's Next? - MarketBeat
KPTI stock touches 52-week low at $0.59 amid market challenges - Investing.com Canada
Karyopharm Therapeutics (STU:25K) Revenue per Share : €1.07 (TTM As of Sep. 2024) - GuruFocus.com
Lacklustre Performance Is Driving Karyopharm Therapeutics Inc.'s (NASDAQ:KPTI) 27% Price Drop - Simply Wall St
Fmr LLC Buys 76,510 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World
KPTI stock touches 52-week low at $0.65 amid market challenges By Investing.com - Investing.com South Africa
KPTI stock touches 52-week low at $0.65 amid market challenges - Investing.com Canada
Karyopharm Therapeutics Inc.'s SWOT analysis: oncology firm's stock faces pivotal trials - Investing.com
Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024 - The Eastern Progress Online
Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications - Kilgore News Herald
Karyopharm Appoints Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications - citybiz
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):